AI, Data, and Venture Capital: Sahir Ali on Smarter Biotech Investing

What happens when a scientist, engineer, and VC see the same future — one where data and biology converge to change medicine?In this episode of The Russo Edge, Sahir Ali, Founder and General Partner of Modi Ventures, joins Solomon Wilcots to discuss how artificial intelligence and data are reshaping the business of biotech. Drawing on his background across programming, Wall Street, and cancer research, Sahir explains how his firm uses a portfolio theory approach to manage risk, identify value, and back the next generation of healthcare breakthroughs.From AI-enabled discovery to Houston’s fast-growing life sciences hub, Sahir offers a window into how venture capital is evolving — and how data-driven strategies can create smarter, more sustainable innovation in biotech.